Differentiate next-generation GLP-1s by quality of weight loss By Shipra Patel, M.D., Therapeutic Area Lead, Endocrinology, Amy Pace, ScD, Vice President, Biostatistics, Nathan Noakes, Sensor Solutions Director The rise of highly effective glucagon-like peptide-1 receptor agonists (GLP-1s) and multi-agonists has transformed obesity research into a multi-billion-dollar industry with strong momentum and fierce competition
Be cautious with processed meats, which can be high in sodium
Additionally, monitoring for signs of biliary complications remains prudent
Some patients report that evening injections may reduce daytime nausea, though this is anecdotal and varies by individual
GET THE MOST OUT OF YOUR SEMAGLUTIDE TREATMENT Should You Exercise While Taking Semaglutide